The Activate study, conducted by the pharmaceutical company Bial R&D Investments, is a recently-started clinical trial to test a new medication for the treatment of Parkinson’s disease in patients with a GBA1 gene mutation.
News | Latest News
TRES AMIGOS - GULP!
Call me crazy, oh what have I done?
It was on, it was off… then there was one,
My thoughts as a solo rider, filled me with fear,
DRIG members made headlines on World Parkinson's day thanks to our local paper - the Courrier, take a look at the articles here:
Marc, Chair of DRIG, recently collected up all the penny collecting pots he had set out around his home town, before Covid and realised over £500, for further research!
What more could a PwP or carer want (or need) to help them through the jungle of articles, reports and Webinars that are all so fascinating, but so easy to get lost in without the requisite scientific background or speakers and authors who talk to the non scientist. If you have an understan